{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:09:58Z","timestamp":1780733398420,"version":"3.54.1"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004366","name":"Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran","doi-asserted-by":"publisher","award":["69440"],"award-info":[{"award-number":["69440"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Induction of immunogenic cell death (ICD) in tumors can enhance antitumor\nimmunity and modulate immunosuppression in the tumor microenvironment (TME).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In the current study, we investigated the effect of silibinin, a natural compound with\nanticancer activity, and its polymer-based nanoformulations on the induction of apoptosis and\nICD in cancer cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Free and nanoparticulate silibinin were evaluated for their growth-inhibitory effects\nusing an MTT assay. Annexin V\/PI staining was used to analyze apoptosis. Calreticulin (CRT)\nexpression was measured by flow cytometry. Western blotting was conducted to examine the\nlevels of elf2\u03b1, which plays a role in the ICD pathway. The HSP90 and ATP levels were determined\nusing specific detection kits.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compared to the free drug, silibinin-loaded nanocarriers significantly increased the\ninduction of apoptosis and ICD in B16F10 cells. ICD induction was characterized by significantly\nincreased levels of ICD biomarkers, including CRT, HSP90, and ATP. We also observed\nan increased expression of p-elf-2\u03b1\/ elf-2\u03b1 in B16F10 cells treated with silibinin-loaded micelles\ncompared to cells that received free silibinin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings showed that the encapsulation of silibinin in polymeric nanocarriers\ncan potentiate the effects of this drug on the induction of apoptosis and ICD in B16F10 melanoma\ncells.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010280336240227062954","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:45:02Z","timestamp":1710405902000},"page":"392-401","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells"],"prefix":"10.2174","volume":"26","author":[{"given":"Mina","family":"Amiri","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevda","family":"Jafari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Lavasanifar","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ommoleila","family":"Molavi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz,\nIran"},{"name":"Biotechnology\nResearch Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Montazersaheb","sequence":"additional","affiliation":[{"name":"Molecular Medicine Research Center, Tabriz\nUniversity of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"Ahmed A.","year":"2020","unstructured":"Ahmed A.; Tait S.W.G.; Targeting immunogenic cell death in cancer. Mol Oncol  2020,14(12),2994-3006","journal-title":"Mol Oncol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.32607\/actanaturae.11523","volume":"14","author":"Troitskaya O.S.","year":"2022","unstructured":"Troitskaya O.S.; Novak D.D.; Richter V.A.; Koval O.A.; Immunogenic cell death in cancer therapy. Acta Nat  2022,14(1),40-53","journal-title":"Acta Nat"},{"key":"ref=3","year":"2024","unstructured":"Immunogenic cell stress and death in the treatment of cancer. Pan, H; Liu, P; Zhao, L; Pan, Y; Mao, M; Kroemer, G, Eds; Seminars in Cell and Developmental Biology  2024","journal-title":"Pan, H; Liu, P; Zhao, L; Pan, Y; Mao, M; Kroemer, G, Eds; Seminars in Cell and Developmental Biology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","volume":"17","author":"Martin J.D.","year":"2020","unstructured":"Martin J.D.; Cabral H.; Stylianopoulos T.; Jain R.K.; Improving cancer immunotherapy using nanomedicines: Progress, opportunities and challenges. Nat Rev Clin Oncol  2020,17(4),251-266","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.genrep.2022.101614","volume":"27","author":"Golbashirzadeh M.","year":"2022","unstructured":"Golbashirzadeh M.; Heidari H.R.; Khosroushahi A.Y.; Molecular mechanisms of reactive oxygen species in regulated cell deaths: Impact of ferroptosis in cancer therapy. Gene Rep  2022,27,101614","journal-title":"Gene Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mc.23183","volume":"59","author":"Ruan H.","year":"2020","unstructured":"Ruan H.; Leibowitz B.J.; Zhang L.; Yu J.; Immunogenic cell death in colon cancer prevention and therapy. Mol Carcinog  2020,59(7),783-793","journal-title":"Mol Carcinog"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"121433","DOI":"10.1016\/j.biomaterials.2022.121433","volume":"282","author":"Zhang S.","year":"2022","unstructured":"Zhang S.; Wang J.; Kong Z.; Sun X.; He Z.; Sun B.; Luo C.; Sun J.; Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy. Biomaterials  2022,282,121433","journal-title":"Biomaterials"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.18632\/oncotarget.27856","volume":"11","author":"Elhassanny A.","year":"2020","unstructured":"Elhassanny A.; Escobedo R.; Ladin D.; Burns C.; Van Dross R.; Damage-associated molecular pattern (DAMP) activation in melanoma: Investigation of the immunogenic activity of 15-deoxy, \u0394 prostamide J. Oncotarget  2020,11(52),4788-4802","journal-title":"Oncotarget"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/cells10010130","volume":"10","author":"Kielbik M.","year":"2021","unstructured":"Kielbik M.; Szulc-Kielbik I.; Klink M.; Calreticulin\u2014multifunctional chaperone in immunogenic cell death: Potential significance as a prognostic biomarker in ovarian cancer patients. Cells  2021,10(1),130","journal-title":"Cells"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10238-022-00937-7","volume":"23","author":"Zhang M.","year":"2022","unstructured":"Zhang M.; Xiao J.; Liu J.; Bai X.; Zeng X.; Zhang Z.; Liu F.; Calreticulin as a marker and therapeutic target for cancer. Clin Exp Med  2022,23(5),1393-1404","journal-title":"Clin Exp Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/cancers13112566","volume":"13","author":"Lamberti M.J.","year":"2021","unstructured":"Lamberti M.J.; Nigro A.; Casolaro V.; Vittar R.N.B.; Dal Col J.; Damage-associated molecular patterns modulation by microRNA: relevance on immunogenic cell death and cancer treatment outcome. Cancers  2021,13(11),2566","journal-title":"Cancers"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"Murao A.","year":"2021","unstructured":"Murao A.; Aziz M.; Wang H.; Brenner M.; Wang P.; Release mechanisms of major DAMPs. Apoptosis  2021,26(3-4),152-162","journal-title":"Apoptosis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/cells10020231","volume":"10","author":"Sansone C.","year":"2021","unstructured":"Sansone C.; Bruno A.; Piscitelli C.; Baci D.; Fontana A.; Brunet C.; Noonan D.M.; Albini A.; Natural compounds of marine origin as inducers of immunogenic cell death (ICD): Potential role for cancer interception and therapy. Cells  2021,10(2),231","journal-title":"Cells"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bcp.2018.12.016","volume":"162","author":"Radogna F.","year":"2019","unstructured":"Radogna F.; Dicato M.; Diederich M.; Natural modulators of the hallmarks of immunogenic cell death. Biochem Pharmacol  2019,162,55-70","journal-title":"Biochem Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12032-023-02145-z","volume":"40","author":"Oliyapour Y.","year":"2023","unstructured":"Oliyapour Y.; Dabiri S.; Molavi O.; Hejazi M.S.; Davaran S.; Jafari S.; Montazersaheb S.; Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells. Med Oncol  2023,40(10),278","journal-title":"Med Oncol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.34172\/bi.2022.23698","volume":"13","author":"Jafari S.","year":"2023","unstructured":"Jafari S.; Heydarian S.; Lai R.; Aghdam M.E.; Molavi O.; Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. Bioimpacts  2023,13(1),51-61","journal-title":"Bioimpacts"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12935-023-03058-7","volume":"23","author":"Amiri M.","year":"2023","unstructured":"Amiri M.; Molavi O.; Sabetkam S.; Jafari S.; Montazersaheb S.; Stimulators of immunogenic cell death for cancer therapy: Focusing on natural compounds. Cancer Cell Int  2023,23(1),200","journal-title":"Cancer Cell Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"153977","DOI":"10.1016\/j.phymed.2022.153977","volume":"99","author":"Su Y.","year":"2022","unstructured":"Su Y.; Wu T.; Yu X.Y.; Huo W.B.; Wang S.H.; Huan C.; Liu Y.M.; Liu J.M.; Cui M.N.; Li X.H.; Yu J.H.; Inhibitory effect of tanshinone IIA, resveratrol and silibinin on enterovirus 68 production through inhibiting ATM and DNA-PK pathway. Phytomedicine  2022,99,153977","journal-title":"Phytomedicine"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"nep164","DOI":"10.1093\/ecam\/nep164","volume":"2011","author":"Haddad Y","year":"2011","unstructured":"Haddad Y; Vallerand D; Brault A; Haddad PS; Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid Based Complement Alternat Med  2011,2011,nep164","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/adt.2022.060","volume":"20","author":"Jafari S.","year":"2022","unstructured":"Jafari S.; Bakhshaei A.; Eskandani M.; Molavi O.; Silibinin-loaded nanostructured lipid carriers for growth inhibition of cisplatin-resistant ovarian cancer cells. Assay Drug Dev Technol  2022,20(8),339-348","journal-title":"Assay Drug Dev Technol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"154594","DOI":"10.1016\/j.phymed.2022.154594","volume":"109","author":"Liu P.","year":"2023","unstructured":"Liu P.; Wang C.; Chen W.; Kang Y.; Liu W.; Qiu Z.; Hayashi T.; Mizuno K.; Hattori S.; Fujisaki H.; Ikejima T.; Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer\u2019s disease models. Phytomedicine  2023,109,154594","journal-title":"Phytomedicine"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"154022","DOI":"10.1016\/j.phymed.2022.154022","volume":"99","author":"Wang J.","year":"2022","unstructured":"Wang J.; Zhang L.; Cao H.; Shi X.; Zhang X.; Gao Z.; Ikeda K.; Yan T.; Jia Y.; Xu F.; Silibinin improves L-cell mass and function through an estrogen receptor-mediated antioxidative mechanism. Phytomedicine  2022,99,154022","journal-title":"Phytomedicine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.hermed.2020.100375","volume":"23","author":"Mashhadi Akbar Boojar M.","year":"2020","unstructured":"Mashhadi Akbar Boojar M.; Boojar M.A.M.; Golmohammad S.; Overview of silibinin anti-tumor effects. J Herb Med  2020,23,100375","journal-title":"J Herb Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"Lin S.R.","year":"2020","unstructured":"Lin S.R.; Chang C.H.; Hsu C.F.; Tsai M.J.; Cheng H.; Leong M.K.; Sung P.J.; Chen J.C.; Weng C.F.; Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol  2020,177(6),1409-1423","journal-title":"Br J Pharmacol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2174\/1871520621666210608101649","volume":"22","author":"Zhou L","year":"2022","unstructured":"Zhou L; Liu J; Meng W; Zhang H; Chen B; valuation of silibinin-loaded microbubbles combined with ultrasound in ovarian cancer cells: Cytotoxicity and mechanisms. Ant-Cancer Agent Med Chemistr  2022,22(7),1320-1327","journal-title":"Ant-Cancer Agent Med Chemistr"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.34172\/bi.2020.11","volume":"10","author":"Rad H.A.","year":"2019","unstructured":"Rad H.A.; Asiaee F.; Jafari S.; Shayanfar A.; Lavasanifar A.; Molavi O.; Poly(ethylene glycol)-poly(\u03b5-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. Bioimpacts  2019,10(2),87-95","journal-title":"Bioimpacts"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2021.07.038","volume":"337","author":"Banstola A.","year":"2021","unstructured":"Banstola A.; Poudel K.; Kim J.O.; Jeong J.H.; Yook S.; Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release  2021,337,505-520","journal-title":"J Control Release"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12032-023-02032-7","volume":"40","author":"Firouzi Amandi A.","year":"2023","unstructured":"Firouzi Amandi A.; Jokar E.; Eslami M.; Dadashpour M.; Rezaie M.; Yazdani Y.; Nejati B.; Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells. Med Oncol  2023,40(6),170","journal-title":"Med Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s10876-023-02404-z","volume":"34","author":"Amirsaadat S.","year":"2023","unstructured":"Amirsaadat S.; Jafari-Gharabaghlou D.; Dadashpour M.; Zarghami N.; Potential anti-proliferative effect of nano-formulated curcumin through modulating micro RNA-132, Cyclin D1, and hTERT genes expression in breast cancer cell lines. J Cluster Sci  2023,34(5),2537-2546","journal-title":"J Cluster Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s11033-022-08171-w","volume":"50","author":"Gharabaghlou J.D.","year":"2023","unstructured":"Gharabaghlou J.D.; Dadashpour M.; khanghah O.J.; Javan S.E.; Zarghami N.; Potentiation of folate-functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: Possible clinical application. Mol Biol Rep  2023,50(4),3023-3033","journal-title":"Mol Biol Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1038\/s41598-020-67510-8","volume":"10","author":"Rasafar N.","year":"2020","unstructured":"Rasafar N.; Barzegar A.; Aghdam M.E.; Structure-based designing efficient peptides based on p53 binding site residues to disrupt p53-MDM2\/X interaction. Sci Rep  2020,10(1),11449","journal-title":"Sci Rep"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10534-022-00426-0","volume":"35","author":"Ghorbanpour M.","year":"2022","unstructured":"Ghorbanpour M.; Soltani B.; Mota A.; Sardroodi J.J.; Aghdam M.E.; Shayanfar A.; Molavi O.; Rezaei M.R.; Nahari E.M.; Ziegler C.J.; Copper (II) complexes with N, S donor pyrazole-based ligands as anticancer agents. Biometals  2022,35(5),1095-1111","journal-title":"Biometals"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1021\/ma0613786","volume":"39","author":"Mahmud A.","year":"2006","unstructured":"Mahmud A.; Xiong X.B.; Lavasanifar A.; Novel self-associating poly (ethylene oxide)-b lock-poly (\u03b5-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery. Macromolecules  2006,39(26),9419-9428","journal-title":"Macromolecules"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1080\/21691401.2016.1269117","volume":"45","author":"Mehdizadeh A.","year":"2017","unstructured":"Mehdizadeh A.; Somi M.H.; Darabi M.; Farajnia S.; Akbarzadeh A.; Montazersaheb S.; Yousefi M.; Bonyadi M.; Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2. Artif Cells Nanomed Biotechnol  2017,45(8),1612-1619","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1016\/j.ijbiomac.2020.09.081","volume":"164","author":"Montazersaheb S.","year":"2020","unstructured":"Montazersaheb S.; Avci \u00c7.B.; Bagca B.G.; Ay N.P.O.; Tarhriz V.; Nielsen P.E.; Charoudeh H.N.; Hejazi M.S.; Targeting TdT gene expression in Molt-4 cells by PNA-octaarginine conjugates. Int J Biol Macromol  2020,164,4583-4590","journal-title":"Int J Biol Macromol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1389201020666190206202650","volume":"20","author":"Montazersaheb S.","year":"2019","unstructured":"Montazersaheb S.; Kazemi M.; Nabat E.; Nielsen P.E.; Hejazi M.S.; Downregulation of TdT expression through splicing modulation by antisense peptide nucleic acid (PNA). Curr Pharm Biotechnol  2019,20(2),168-178","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.biopha.2018.09.135","volume":"108","author":"Montazersaheb S.","year":"2018","unstructured":"Montazersaheb S.; Kabiri F.; Saliani N.; Nourazarian A.; Avci \u00c7.B.; Rahbarghazi R.; Charoudeh N.H.; Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells. Biomed Pharmacother  2018,108,1328-1337","journal-title":"Biomed Pharmacother"},{"key":"ref=38","first-page":"1583","volume":"24","author":"Fathi E.","year":"2021","unstructured":"Fathi E.; Vandghanooni S.; Montazersaheb S.; Farahzadi R.; Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length. Iran J Basic Med Sci  2021,24(11),1583-1589","journal-title":"Iran J Basic Med Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.18433\/jpps30427","volume":"22","author":"Farjami A.","year":"2019","unstructured":"Farjami A.; Siahi-Shadbad M.; Akbarzadehlaleh P.; Roshanzamir K.; Molavi O.; Evaluation of the physicochemical and biological stability of cetuximab under various stress condition. J Pharm Pharm Sci  2019,22(1),171-190","journal-title":"J Pharm Pharm Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1177\/0960327121993224","volume":"40","author":"Rahimi M.M.","year":"2021","unstructured":"Rahimi M.M.; Bagheri A.; Bagheri Y.; Fathi E.; Bagheri S.; Nia A.V.; Jafari S.; Montazersaheb S.; Renoprotective effects of prazosin on ischemia-reperfusion injury in rats. Hum Exp Toxicol  2021,40(8),1263-1273","journal-title":"Hum Exp Toxicol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"117223","DOI":"10.1016\/j.lfs.2019.117223","volume":"242","author":"Valipour B.","year":"2020","unstructured":"Valipour B.; Abedelahi A.; Naderali E.; Velaei K.; Movassaghpour A.; Talebi M.; Montazersaheb S.; Karimipour M.; Darabi M.; Chavoshi H.; Charoudeh N.H.; Cord blood stem cell derived CD16 NK cells eradicated acute lymphoblastic leukemia cells using with anti-CD47 antibody. Life Sci  2020,242,117223","journal-title":"Life Sci"},{"key":"ref=42","first-page":"175","volume":"24","author":"Bagheri Y.","year":"2021","unstructured":"Bagheri Y.; Barati A.; Nouraei S.; Namini J.N.; Bakhshi M.; Fathi E.; Montazersaheb S.; Comparative study of gavage and intraperitoneal administration of gamma-oryzanol in alleviation\/attenuation in a rat animal model of renal ischemia\/reperfusion-induced injury. Iran J Basic Med Sci  2021,24(2),175-183","journal-title":"Iran J Basic Med Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1002\/jcb.26842","volume":"119","author":"Ghaderi S.","year":"2018","unstructured":"Ghaderi S.; Alidadiani N.; SoleimaniRad J.; Heidari H.R.; Dilaver N.; Heim C.; Gleixner R.M.; Baradaran B.; Weyand M.; DJ1 and microRNA\u2010214 act synergistically to rescue myoblast cells after ischemia\/reperfusion injury. J Cell Biochem  2018,119(9),7192-7203","journal-title":"J Cell Biochem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s00210-021-02160-9","volume":"394","author":"Bagheri Y.","year":"2021","unstructured":"Bagheri Y.; Eteghad S.S.; Fathi E.; Mahmoudi J.; Abdollahpour A.; Namini N.J.; Malekinejad Z.; Mokhtari K.; Barati A.; Montazersaheb S.; Hepatoprotective effects of sericin on aging-induced liver damage in mice. Naunyn Schmiedebergs Arch Pharmacol  2021,394(12),2441-2450","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/ijms19020594","volume":"19","author":"Montico B.","year":"2018","unstructured":"Montico B.; Nigro A.; Casolaro V.; Dal Col J.; Immunogenic apoptosis as a novel tool for anticancer vaccine development. Int J Mol Sci  2018,19(2),594","journal-title":"Int J Mol Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.actbio.2023.02.011","volume":"160","author":"Feng X.","year":"2023","unstructured":"Feng X.; Lin T.; Chen D.; Li Z.; Yang Q.; Tian H.; Xiao Y.; Lin M.; Liang M.; Guo W.; Zhao P.; Guo Z.; Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2\u03b1 pathway under PTT\/CDT combined therapy. Acta Biomater  2023,160,211-224","journal-title":"Acta Biomater"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.7150\/thno.42243","volume":"10","author":"Sethuraman S.N.","year":"2020","unstructured":"Sethuraman S.N.; Singh M.P.; Patil G.; Li S.; Fiering S.; Hoopes P.J.; Guha C.; Malayer J.; Ranjan A.; Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity. Theranostics  2020,10(8),3397-3412","journal-title":"Theranostics"},{"key":"ref=48","year":"2015","unstructured":"eIF2\u03b1 phosphorylation as a biomarker of immunogenic cell death. Kepp, O; Semeraro, M; Pedro, BSJM; Bloy, N; Buqu\u00e9, A; Huang, X, Eds; Seminars in cancer biology  2015","journal-title":"Kepp, O; Semeraro, M; Pedro, BSJM; Bloy, N; Buqu\u00e9, A; Huang, X, Eds; Seminars in cancer biology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lfs.2017.08.003","volume":"186","author":"Cao Y.","year":"2017","unstructured":"Cao Y.; Long J.; Liu L.; He T.; Jiang L.; Zhao C.; Li Z.; A review of endoplasmic reticulum (ER) stress and nanoparticle (NP) exposure. Life Sci  2017,186,33-42","journal-title":"Life Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12011-019-01903-3","volume":"196","author":"Rana S.V.S.","year":"2020","unstructured":"Rana S.V.S.; Endoplasmic reticulum stress induced by toxic elements\u2014A review of recent developments. Biol Trace Elem Res  2020,196(1),10-19","journal-title":"Biol Trace Elem Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/bs.mcb.2022.01.003","volume":"172","author":"Bezu L.","year":"2022","unstructured":"Bezu L.; Humeau J.; Leduc M.; Pan H.; Kroemer G.; Kepp O.; Assessment of eIF2\u03b1 phosphorylation during immunogenic cell death. Methods Cell Biol  2022,172,83-98","journal-title":"Methods Cell Biol"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp.82990","volume":"15","author":"Molavi O.","year":"2019","unstructured":"Molavi O.; Torkzaban F.; Jafari S.; Asnaashari S.; Asgharian P.; Chemical compositions and anti-proliferative activity of the aerial parts and rhizomes of squirting cucumber, Cucurbitaceae. Jundishapur J Nat Pharm Prod  2019,15(1)","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12272-019-01150-z","volume":"42","author":"Diederich M.","year":"2019","unstructured":"Diederich M.; Natural compound inducers of immunogenic cell death. Arch Pharm Res  2019,42(7),629-645","journal-title":"Arch Pharm Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"128429","DOI":"10.1016\/j.colsurfa.2022.128429","volume":"640","author":"Mollazadeh S.","year":"2022","unstructured":"Mollazadeh S.; Babaei S.; Ostadhassan M.; Robati Y.R.; Concentration-dependent assembly of Bovine serum albumin molecules in the doxorubicin loading process: Molecular dynamics simulation. Colloids Surf A Physicochem Eng Asp  2022,640,128429","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2174\/1389201024666221221113020","volume":"24","author":"Jantan I.","year":"2023","unstructured":"Jantan I.; Wahab A.S.M.; Husain K.; Arshad L.; Haque M.A.; Fauzi M.N.; Nafiah M.A.; Das S.; Immunosuppressive effects of Annona muricata L. leaf extract on cellular and humoral immune responses in male wistar rats. Curr Pharm Biotechnol  2023,24(11),1465-1477","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1389201021666200212093130","volume":"21","author":"Chen W.","year":"2020","unstructured":"Chen W.; Wang S.; Wu Y.; Shen X.; Xu S.; Guo Z.; Zhang R.; Xing D.; The physiologic activity and mechanism of quercetin-like natural plant flavonoids. Curr Pharm Biotechnol  2020,21(8),654-658","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=57","author":"Upadhyay P.K.","year":"2024","unstructured":"Upadhyay P.K.; Singh S.; Vishwakarma V.K.; Natural polyphenols in cancer management: Promising role, mechanisms, and chemistry. Curr Pharm Biotechnol  2024","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13880209.2016.1270972","volume":"55","author":"Molavi O.","year":"2017","unstructured":"Molavi O.; Narimani F.; Asiaee F.; Sharifi S.; Tarhriz V.; Shayanfar A.; Hejazi M.; Lai R.; Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy. Pharm Biol  2017,55(1),729-739","journal-title":"Pharm Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12935-023-02936-4","volume":"23","author":"Singh M.","year":"2023","unstructured":"Singh M.; Kadhim M.M.; Turki Jalil A.; Oudah S.K.; Aminov Z.; Alsaikhan F.; Jawhar Z.H.; Coronel R.A.A.; Farhood B.; A systematic review of the protective effects of silymarin\/silibinin against doxorubicin-induced cardiotoxicity. Cancer Cell Int  2023,23(1),88","journal-title":"Cancer Cell Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1080\/15563650.2022.2128815","volume":"60","author":"Horowitz Z.B.","year":"2022","unstructured":"Horowitz Z.B.; Silibinin: A toxicologist\u2019s herbal medicine? Clin Toxicol  2022,60(11),1194-1197","journal-title":"Clin Toxicol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2174\/1871520620666191220142741","volume":"20","author":"Binienda A","year":"2020","unstructured":"Binienda A; Ziolkowska S; Pluciennik E; The anticancer properties of silibinin: Its molecular mechanism and therapeutic effect in breast cancer. Anticancer Agents Med Chem  2020,20(15),1787-1796","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.colsurfb.2016.01.003","volume":"140","author":"Bernabeu E.","year":"2016","unstructured":"Bernabeu E.; Gonzalez L.; Cagel M.; Gergic E.P.; Moretton M.A.; Chiappetta D.A.; Novel soluplus  \u2014TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces  2016,140,403-411","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/1574892815666201006124604","volume":"15","author":"Kazemi M.","year":"2020","unstructured":"Kazemi M.; Emami J.; Hasanzadeh F.; Minaiyan M.; Mirian M.; Lavasanifar A.; Mokhtari M.; In vitro and in vivo evaluation of novel DTX-loaded multifunctional heparin-based polymeric micelles targeting folate receptors and endosomes. Recent Patents Anticancer Drug Discov  2020,15(4),341-359","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.xphs.2019.03.016","volume":"108","author":"Al-Lawati H.","year":"2019","unstructured":"Al-Lawati H.; Vakili M.R.; Lavasanifar A.; Ahmed S.; Jamali F.; Delivery and biodistribution of traceable polymeric micellar diclofenac in the rat. J Pharm Sci  2019,108(8),2698-2707","journal-title":"J Pharm Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","volume":"332","author":"Ghosh B.","year":"2021","unstructured":"Ghosh B.; Biswas S.; Polymeric micelles in cancer therapy: State of the art. J Control Release  2021,332,127-147","journal-title":"J Control Release"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"101872","DOI":"10.1016\/j.jddst.2020.101872","volume":"59","author":"Saadat M.","year":"2020","unstructured":"Saadat M.; Jafari S.; Zakeri-Milani P.; Shahbazi-Mojarrad J.; Valizadeh H.; Stearoylcholine and oleoylcholine: Synthesis, physico-chemical characterization, nanoparticle formation, and toxicity studies. J Drug Deliv Sci Technol  2020,59,101872","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.31557\/APJCP.2020.21.7.1877","volume":"21","author":"Iyangar M.R.","year":"2020","unstructured":"Iyangar M.R.; Devaraj E.; Silibinin triggers the mitochondrial pathway of apoptosis in human Oral squamous carcinoma cells. Asian Pac J Cancer Prev  2020,21(7),1877-1882","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"151620","DOI":"10.1016\/j.acthis.2020.151620","volume":"122","author":"Guo H.","year":"2020","unstructured":"Guo H.; Wang Y.; Liu D.; Silibinin ameliorats HO-induced cell apoptosis and oxidative stress response by activating Nrf2 signaling in trophoblast cells. Acta Histochem  2020,122(8),151620","journal-title":"Acta Histochem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40199-020-00326-z","volume":"28","author":"Jafari S.","year":"2020","unstructured":"Jafari S.; Lavasanifar A.; Hejazi M.S.; Maleki-Dizaji N.; Mesgari M.; Molavi O.; STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells. Daru  2020,28(1),159-169","journal-title":"Daru"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-319-67577-0_5","volume":"1036","author":"Pitt J.M.","year":"2017","unstructured":"Pitt J.M.; Kroemer G.; Zitvogel L.; Immunogenic and non-immunogenic cell death in the tumor microenvironment. Adv Exp Med Biol  2017,1036,65-79","journal-title":"Adv Exp Med Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cancers12041047","volume":"12","author":"Asadzadeh Z.","year":"2020","unstructured":"Asadzadeh Z.; Safarzadeh E.; Safaei S.; Baradaran A.; Mohammadi A.; Hajiasgharzadeh K.; Derakhshani A.; Argentiero A.; Silvestris N.; Baradaran B.; Current approaches for combination therapy of cancer: The role of immunogenic cell death. Cancers  2020,12(4),1047","journal-title":"Cancers"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","volume":"102","author":"Zhao X.","year":"2016","unstructured":"Zhao X.; Yang K.; Zhao R.; Ji T.; Wang X.; Yang X.; Zhang Y.; Cheng K.; Liu S.; Hao J.; Ren H.; Leong K.W.; Nie G.; Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Biomaterials  2016,102,187-197","journal-title":"Biomaterials"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"e25961","DOI":"10.4161\/onci.25961","volume":"2","author":"Devaud C.","year":"2013","unstructured":"Devaud C.; John L.B.; Westwood J.A.; Darcy P.K.; Kershaw M.H.; Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. OncoImmunology  2013,2(8),e25961","journal-title":"OncoImmunology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"Kroemer G.","year":"2013","unstructured":"Kroemer G.; Galluzzi L.; Kepp O.; Zitvogel L.; Immunogenic cell death in cancer therapy. Annu Rev Immunol  2013,31(1),51-72","journal-title":"Annu Rev Immunol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","volume":"153","author":"Radogna F.","year":"2018","unstructured":"Radogna F.; Diederich M.; Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy. Biochem Pharmacol  2018,153,12-23","journal-title":"Biochem Pharmacol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010280336240227062954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227908\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010280336240227062954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:51:05Z","timestamp":1738234265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227908\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010280336240227062954","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}